Identification of novel allosteric inhibitors of mutant isocitrate dehydrogenase 1 by cross docking-based virtual screening
IDH1 mutation (mIDH1) occurs in 20-30% of gliomas and is a promising target for the cancer therapy. In this article, a cross docking-based virtual screening was employed to identify seven small molecules for the allosteric site of mIDH1. Compounds ZX01, ZX05 and ZX06 exhibited the potent inhibitory...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2018
|
| In: |
Bioorganic & medicinal chemistry letters
Year: 2017, Jahrgang: 28, Heft: 3, Pages: 388-393 |
| ISSN: | 1464-3405 |
| DOI: | 10.1016/j.bmcl.2017.12.030 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.bmcl.2017.12.030 Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0960894X17311903 
|
| Verfasserangaben: | Fangxia Zou, Stefan Pusch, Jie Hua, Tianfang Ma, Lijun Yang, Qihua Zhu, Yungen Xu, Yueqing Gu, Andreas von Deimling, Xiaoming Zha |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1694036707 | ||
| 003 | DE-627 | ||
| 005 | 20230427100354.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200403r20182017xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bmcl.2017.12.030 |2 doi | |
| 035 | |a (DE-627)1694036707 | ||
| 035 | |a (DE-599)KXP1694036707 | ||
| 035 | |a (OCoLC)1341313726 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Zou, Fangxia |e VerfasserIn |0 (DE-588)1165340984 |0 (DE-627)1029424330 |0 (DE-576)510370195 |4 aut | |
| 245 | 1 | 0 | |a Identification of novel allosteric inhibitors of mutant isocitrate dehydrogenase 1 by cross docking-based virtual screening |c Fangxia Zou, Stefan Pusch, Jie Hua, Tianfang Ma, Lijun Yang, Qihua Zhu, Yungen Xu, Yueqing Gu, Andreas von Deimling, Xiaoming Zha |
| 264 | 1 | |c 2018 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Available online 13 December 2017 | ||
| 500 | |a Gesehen am 24.06.2020 | ||
| 520 | |a IDH1 mutation (mIDH1) occurs in 20-30% of gliomas and is a promising target for the cancer therapy. In this article, a cross docking-based virtual screening was employed to identify seven small molecules for the allosteric site of mIDH1. Compounds ZX01, ZX05 and ZX06 exhibited the potent inhibitory activity and the high selectivity against WT-IDH1, providing a good starting point for the further development of highly selective mIDH1 inhibitors. Importantly, the parallel artificial membrane permeation assay of the blood-brain barrier (PAMPA-BBB) identified ZX06 with a good ability to penetrate BBB. These findings indicate that ZX06 deserves further optimization as a lead compound for the treatment of patients with IDH1 mutated brain cancers. | ||
| 534 | |c 2017 | ||
| 650 | 4 | |a Allosteric | |
| 650 | 4 | |a BBB | |
| 650 | 4 | |a Docking | |
| 650 | 4 | |a Gliomas | |
| 650 | 4 | |a Inhibitors | |
| 650 | 4 | |a Mutant IDH1 | |
| 700 | 1 | |a Pusch, Stefan |d 1979- |e VerfasserIn |0 (DE-588)137014155 |0 (DE-627)58945224X |0 (DE-576)30150623X |4 aut | |
| 700 | 1 | |a Deimling, Andreas von |d 1959- |e VerfasserIn |0 (DE-588)103034115X |0 (DE-627)735093946 |0 (DE-576)378138065 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bioorganic & medicinal chemistry letters |d Amsterdam [u.a.] : Elsevier Science, 1991 |g 28(2018), 3, Seite 388-393 |h Online-Ressource |w (DE-627)306717522 |w (DE-600)1501505-1 |w (DE-576)110916573 |x 1464-3405 |7 nnas |a Identification of novel allosteric inhibitors of mutant isocitrate dehydrogenase 1 by cross docking-based virtual screening |
| 773 | 1 | 8 | |g volume:28 |g year:2018 |g number:3 |g pages:388-393 |g extent:6 |a Identification of novel allosteric inhibitors of mutant isocitrate dehydrogenase 1 by cross docking-based virtual screening |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.bmcl.2017.12.030 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S0960894X17311903 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200403 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 103034115X |a Deimling, Andreas von |m 103034115X:Deimling, Andreas von |d 910000 |d 912000 |e 910000PD103034115X |e 912000PD103034115X |k 0/910000/ |k 1/910000/912000/ |p 9 | ||
| 998 | |g 137014155 |a Pusch, Stefan |m 137014155:Pusch, Stefan |d 910000 |d 912000 |e 910000PP137014155 |e 912000PP137014155 |k 0/910000/ |k 1/910000/912000/ |p 2 | ||
| 999 | |a KXP-PPN1694036707 |e 3618445482 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"2018"}],"name":{"displayForm":["Fangxia Zou, Stefan Pusch, Jie Hua, Tianfang Ma, Lijun Yang, Qihua Zhu, Yungen Xu, Yueqing Gu, Andreas von Deimling, Xiaoming Zha"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1694036707","id":{"doi":["10.1016/j.bmcl.2017.12.030"],"eki":["1694036707"]},"person":[{"given":"Fangxia","display":"Zou, Fangxia","role":"aut","family":"Zou"},{"display":"Pusch, Stefan","role":"aut","family":"Pusch","given":"Stefan"},{"family":"Deimling","role":"aut","display":"Deimling, Andreas von","given":"Andreas von"}],"language":["eng"],"note":["Available online 13 December 2017","Gesehen am 24.06.2020"],"title":[{"title":"Identification of novel allosteric inhibitors of mutant isocitrate dehydrogenase 1 by cross docking-based virtual screening","title_sort":"Identification of novel allosteric inhibitors of mutant isocitrate dehydrogenase 1 by cross docking-based virtual screening"}],"physDesc":[{"extent":"6 S."}],"relHost":[{"origin":[{"dateIssuedDisp":"1991-","dateIssuedKey":"1991","publisherPlace":"Amsterdam [u.a.]","publisher":"Elsevier Science"}],"disp":"Identification of novel allosteric inhibitors of mutant isocitrate dehydrogenase 1 by cross docking-based virtual screeningBioorganic & medicinal chemistry letters","type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"306717522","id":{"eki":["306717522"],"zdb":["1501505-1"],"issn":["1464-3405"]},"language":["eng"],"pubHistory":["1.1991 -"],"titleAlt":[{"title":"Bioorganic and medicinal chemistry letters"}],"note":["Gesehen am 09.11.2020"],"part":{"pages":"388-393","year":"2018","issue":"3","extent":"6","text":"28(2018), 3, Seite 388-393","volume":"28"},"title":[{"title":"Bioorganic & medicinal chemistry letters","title_sort":"Bioorganic & medicinal chemistry letters","subtitle":"a Tetrahedron publication for rapid dissemination of preliminary communications on all aspects of bioorganic chemistry, medicinal chemistry, bioinorganic chemistry and related disciplines"}],"physDesc":[{"extent":"Online-Ressource"}]}]} | ||
| SRT | |a ZOUFANGXIAIDENTIFICA2018 | ||